Learn More
OBJECTIVE To evaluate abatacept therapy in patients with non-life-threatening systemic lupus erythematosus (SLE) and polyarthritis, discoid lesions, or pleuritis and/or pericarditis. METHODS In a(More)
OBJECTIVES To analyse the capacity of routine assessment of patient index data 3 (RAPID3), an index of only the three patient-reported outcome (PRO) measures in the RA Core Data Set-physical(More)
• Several approved therapies have shown results that are inconsistent in terms of statistical significance on this endpoint when evaluated in 2 pivotal RRMS trials for superiority versus the same(More)
INTRODUCTION Multiple sclerosis (MS) is an autoimmune neurodegenerative disease of the central nervous system involving inflammation, chronic demyelination and axonal loss. MS affects more than 2(More)
  • 1